click on circles to display study description...
anticoagulant, curative dose (n=591) vs. anticoagulant, prophylactic dose (n=616)
randomized controlled trial
therapeutic anticoagulation with heparin
Therapeutic anticoagulation was administered according to local site protocols for the treatment of acute venous thromboembolism for up to 14 days or recovery
pharmacological thromboprophylaxis as per local usual care
COVID-19 severe or critically
open-blind
NCT02735707, NCT04505774, NCT04359277, NCT04372589
anticoagulant, curative dose (n=191) vs. anticoagulant, prophylactic dose (n=191)
randomized controlled trial
full-dose anticoagulation
standard-dose prophylactic anticoagulation
COVID-19 severe or critically
open label
34 centers, United States
2x2 factorial deisgn with clopidogrel or no antiplatelet therapy; recruitment was stopped early in 03/2022 (∼50% planned recruitment) due to waning ICU-level COVID-19 rates
powered by vis.js Network
- About us - Contact us - Method - RSS Made with in Lyon - Credits - Privacy policy -
An extraction panel is open